1. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: A Cancer J clinicians,2018
3. Liver cancer: regorafenib as second-line therapy in hepatocellular carcinoma;Duffy;Nat Rev Gastroenterol Hepatol,2017
4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008